Perceptive Advisors »

Pepgen shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Pepgen (PEPG) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Pepgen

Tip: Access up to 7 years of quarterly data

All positions including Pepgen held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pepgen by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $21M 1.4M 14.70

More positions owned by Perceptive Advisors

Cerevel Therapeutics Hldng I (CERE)
Amicus Therapeutics (FOLD)
Iovance Biotherapeutics (IOVA)
Arcellx Common Stock (ACLX)
Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Inhibrx (INBX)
Fusion Pharmaceuticals (FUSN)
Rhythm Pharmaceuticals (RYTM)
Vaxcyte (PCVX)
Soleno Therapeutics (SLNO)
Medtronic SHS (MDT)
Madrigal Pharmaceuticals (MDGL)
Springworks Therapeutics (SWTX)
Neurocrine Biosciences (NBIX)

View all positions for Perceptive Advisors

Top funds holding Pepgen

RA Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
Viking Global Investors
Perceptive Advisors
Adage Capital Partners GP
Henderson Group
Vanguard Group
Laurion Capital Management
BlackRock
Sofinnova Ventures
FMR
Octagon Capital Advisors
Geode Capital Management
State Street Corporation

View all funds holding Pepgen